Back to Market Feed

EXELON 13.3 MG/24HR PATCH

rivastigmine
$22.0078per EA
High Outlier

Strength

13.3 mg/24h

NDC

00078050315

Classification

Brand

Dosage Form

PATCH, EXTENDED RELEASE

Route

TRANSDERMAL

Last Updated

9/17/2025

Active Ingredients

RIVASTIGMINE

Approval Type

New Drug (NDA)

FDA Application

NDA022083

On Market Since

7/6/2007

Pharmacological Classes

Cholinesterase Inhibitor
Cholinesterase Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

+0.1%

3Y

+0.7%

5Y

+0.8%

All

+119.0%

Generic Alternatives

Save up to 91%

2 alternatives • Same active ingredient

RIVASTIGMINE 13.3 MG/24HR PTCH
Generic
00378907293•Mylan Pharmaceuticals Inc.
$1.9469
Save 91%
RIVASTIGMINE 13.3 MG/24HR PTCH
Generic
00781731331•Sandoz Inc.
$1.9469
Save 91%

Related Drugs

Same classification

MESTINON 60 MG/5 ML SYRUP
Brand
00187301220•Bausch Health US LLC
$1.9930
per ML
ARICEPT 23 MG TABLET
Brand
62856024730•Eisai Inc.
$14.3864
per EA
ARICEPT 10 MG TABLET
Brand
62856024630•Eisai Inc.
$16.1969
per EA
ARICEPT 5 MG TABLET
Brand
62856024530•Eisai Inc.
$16.4368
per EA
NAMZARIC 21 MG-10 MG CAPSULE
Brand
00456122130•Allergan, Inc.
$19.7649
per EA
NAMZARIC 28 MG-10 MG CAPSULE
Brand
00456122830•Allergan, Inc.
$19.8156
per EA
NAMZARIC 7 MG-10 MG CAPSULE
Brand
00456120730•Allergan, Inc.
$19.8250
per EA
NAMZARIC 14 MG-10 MG CAPSULE
Brand
00456121430•Allergan, Inc.
$19.8307
per EA
MESTINON 60 MG TABLET
Brand
00187301030•Bausch Health US LLC
$20.7334
per EA
MESTINON 180 MG TIMESPAN
Brand
00187301330•Bausch Health US LLC
$39.3384
per EA